Diljeet K. Singh - Concepedia

Concepedia

Author

Diljeet K. Singh

Northwestern University

Also Known As

D K. Singh, D. K. Singh, D. Singh, D.K. Singh, Dharmendra Singh, Diljeet K Singh, Diljeet K. Singh, Diljeet Singh, Diljeet K. Singh

48

Publications

1.8K

Citations

22

H-Index

40

Concepts

All Affiliations

Northwestern University The University of Texas MD Anderson Cancer Center John H. Stroger, Jr. Hospital of Cook County Stanford University Montefiore Medical Center

DK

About

Diljeet K. Singh is an author at Northwestern University specializing in obstetrics, medicine, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	13	988
2	Obstetrics	13	13	988
3	Public Health	3	3	180
4	Cell Biology	2	2	116
5	Health Policy	1	1	68

Diljeet K. Singh

×

25

Publications

1.8K

Citations

21

H-Index

	Year	Citations
The role of ultrasound evaluation in the detection of early-stage epithelial ovarian cancer David A. Fishman, Leeber Cohen, Stephanie V. Blank, American Journal of Obstetrics and Gynecology Ultrasound EvaluationMedical UltrasoundCancer DetectionPower UltrasoundMedicine	2005	174
Intraoperative Neuraxial Anesthesia But Not Postoperative Neuraxial Analgesia Is Associated With Increased Relapse-Free Survival in Ovarian Cancer Patients After Primary Cytoreductive Surgery Gildàsio S. De Oliveira, Shireen Ahmad, Julian C. Schink, Regional Anesthesia & Pain Medicine	2011	173
Predictors of final histology in patients with endometrial cancer Michael Frumovitz, Diljeet K. Singh, Larissa Meyer, Gynecologic Oncology Tumoral PathologyEndocrine-related CancerMedicineSurgical PathologyHistopathology	2004	145
Frozen section analyses as predictors of lymphatic spread in patients with early-stage uterine cancer1 Michael Frumovitz, Brian M. Slomovitz, Diljeet K. Singh, Journal of the American College of Surgeons	2004	135
Hypersensitivity Reactions and the Utility of Oral and Intravenous Desensitization in Patients with Gynecologic Malignancies Jubilee B. Robinson, Diljeet K. Singh, Diane C. Bodurka, Gynecologic Oncology Drug HypersensitivityOncologyGynecologic MalignanciesMedicineMetronomic Therapy	2001	112
Treatment of high-risk gestational trophoblastic neoplasia with etoposide, methotrexate, actinomycin D, cyclophosphamide, and vincristine chemotherapy☆ Pedro F. Escobar, John R. Lurain, Diljeet K. Singh, Gynecologic Oncology Actinomycin DMedicinePathologyGynecologyVincristine Chemotherapy☆	2003	104
Human Papillomavirus Infection and Cervical Cytology in HIV‐Infected and HIV‐Uninfected Rwandan Women Diljeet K. Singh, Kathryn Anastos, Donald R. Hoover, The Journal of Infectious Diseases	2009	102
Survival and reproductive outcomes in women treated for malignant ovarian germ cell tumors Lori Weinberg, John R. Lurain, Diljeet K. Singh, Gynecologic Oncology Germ CellReproductive OutcomesMedicineCancer ManagementReproductive Health	2011	90
Primary treatment of metastatic high-risk gestational trophoblastic neoplasia with EMA-CO chemotherapy. John R. Lurain, Diljeet K. Singh, Julian C. Schink PubMed	2006	85
The Regulation and Function of the Forkhead Transcription Factor, Forkhead Box O1, Is Dependent on the Progesterone Receptor in Endometrial Carcinoma Erin C. Ward, Anna V. Hoekstra, Leen J. Blok, Endocrinology Tumor BiologyProgesterone ReceptorForkhead Transcription FactorMedicineHormonal Receptor	2007	79

Page 1